Drug interactions
Dichlorphenamide + Obinutuzumab
Severity: Minor
Dichlorphenamide and Obinutuzumab: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Dichlorphenamide lowers serum potassium and bicarbonate, while obinutuzumab is not an established cause of hypokalemia. Any link relates mainly to tumor lysis syndrome and its electrolyte shifts, so a direct additive effect is speculative.
What this interaction means in plain words
Dichlorphenamide and Obinutuzumab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Dichlorphenamide belongs to Miscellaneous; Obinutuzumab belongs to Oncology.
Why it happens
No established direct mechanism; any effect is theoretical.
What to do
Monitor electrolytes and renal function as part of standard tumor lysis prevention. No specific adjustment to dichlorphenamide is needed.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dichlorphenamide and Obinutuzumab, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Dichlorphenamide
Other interactions of Obinutuzumab
Frequently asked questions
Can I take Dichlorphenamide with Obinutuzumab?
MediHelp rates the interaction as minor. Dichlorphenamide and Obinutuzumab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Dichlorphenamide lowers serum potassium and bicarbonate, while obinutuzumab is not an established cause of hypokalemia. Any link relates mainly to tumor lysis syndrome and its electrolyte shifts, so a direct additive effect is speculative.
How serious is the interaction between Dichlorphenamide and Obinutuzumab?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor electrolytes and renal function as part of standard tumor lysis prevention. No specific adjustment to dichlorphenamide is needed.
What other medicines interact with Dichlorphenamide?
MediHelp also lists interactions of Dichlorphenamide with, for example, Acetazolamide, Acetylsalicylic acid, Ammonium chloride. The full list is on the Dichlorphenamide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
